Abstract 3696: Liquid biopsy biomarker analysis during treatment with 177Lu-PSMA-617 in castrate resistant prostate cancer
Jamie M. Sperger(University of Wisconsin–Madison), Joshua M. Lang(University of Wisconsin–Madison), Marina N. Sharifi(University of Wisconsin–Madison), Amy K. Taylor(University of Wisconsin–Madison), Shuang G. Zhao(University of Wisconsin Carbone Cancer Center), John M. Floberg(University of Wisconsin–Madison), Luke A. Nunamaker(University of Wisconsin–Madison), Charlotte Linebarger(University of Wisconsin–Madison), Grace C. Bliitzer(University of Wisconsin–Madison), Shannon R. Reese(University of Wisconsin–Madison), V. Carreño(University of Wisconsin–Madison), Alex H. Chang(University of Wisconsin Carbone Cancer Center)
Cited by 1
Related Papers
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2019|1.6k
Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors
|Proceedings of the National Academy of Sciences|2003|650
Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2023|592
NCCN Guidelines Insights: Prostate Cancer, Version 1.2021
|Journal of the National Comprehensive Cancer Network|2021|532